Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014


#225037

77pages

GlobalData

$ 2500

In Stock


GlobalData's clinical trial report, Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables4
List of Figures 5

Introduction 6
Ischemic Cardiomyopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ischemic Cardiomyopathy 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ischemic Cardiomyopathy Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Ischemic Cardiomyopathy 32
Aug 22, 2014: Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Celladon Corporation 33
Clinical Trial Overview of Celladon Corporation 33
Medtronic CardioVascular, Inc. 34
Clinical Trial Overview of Medtronic CardioVascular, Inc. 34
Medistem, Inc. 35
Clinical Trial Overview of Medistem, Inc. 35
Kolding Sygehus 36
Clinical Trial Overview of Kolding Sygehus 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Bioheart, Inc. 38
Clinical Trial Overview of Bioheart, Inc. 38
Ajanta Pharma Limited 39
Clinical Trial Overview of Ajanta Pharma Limited 39
Advanced Cell Technology, Inc. 40
Clinical Trial Overview of Advanced Cell Technology, Inc. 40
Aastrom Biosciences, Inc. 41
Clinical Trial Overview of Aastrom Biosciences, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Osaka University 42
Clinical Trial Overview of Osaka University 42
Johns Hopkins University 43
Clinical Trial Overview of Johns Hopkins University 43
AHEPA University Hospital 44
Clinical Trial Overview of AHEPA University Hospital 44
ASKLEPIOS proresearch Klinische Forschung und Entwicklung 45
Clinical Trial Overview of ASKLEPIOS proresearch Klinische Forschung und Entwicklung 45
Kyoto Prefectural University of Medicine 46
Clinical Trial Overview of Kyoto Prefectural University of Medicine 46
Chiba University Hospital 47
Clinical Trial Overview of Chiba University Hospital 47
University of Louisville 48
Clinical Trial Overview of University of Louisville 48
Cedars-Sinai Medical Center 49
Clinical Trial Overview of Cedars-Sinai Medical Center 49
Johann Wolfgang Goethe University Hospitals 50
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 50
University of Rochester 51
Clinical Trial Overview of University of Rochester 51
Five Key Clinical Profiles 52

Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Ischemic Cardiomyopathy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Ischemic Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2014* 33
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic CardioVascular, Inc., 2014* 34
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2014* 35
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kolding Sygehus, 2014* 36
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 37
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioheart, Inc., 2014* 38
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2014* 39
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Advanced Cell Technology, Inc., 2014* 40
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 41
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 42
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 43
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AHEPA University Hospital, 2014* 44
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by ASKLEPIOS proresearch Klinische Forschung und Entwicklung, 2014* 45
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2014* 46
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2014* 47
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2014* 48
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 49
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 50
Ischemic Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 51

Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Ischemic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Ischemic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Ischemic Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Ischemic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Ischemic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Ischemic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 76